Vistagen Therapeutics (VTGN) Stock Chart & Stock Price History → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free VTGN Stock Alerts $4.50 +0.09 (+2.04%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vistagen Therapeutics Stock Price Performance5 Day Performance-5.66%1 Month Performance-14.93%3 Month Performance-5.66%6 Month Performance+34.33%Year-To-Date Performance-12.45%1 Year Performance+19.43% Receive VTGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here VTGN Stock Chart for Saturday, May, 4, 2024 VTGN Chart by TradingView Vistagen Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$4.41$4.50+2.04%$4.55$4.31190,500 shs$121.59 million05/02/2024$4.74$4.41-6.96%$4.82$4.37318,489 shs$119.16 million05/01/2024$4.83$4.74-1.86%$4.93$4.72132,014 shs$128.08 million04/30/2024$4.77$4.83+1.26%$4.96$4.65474,142 shs$130.51 million04/29/2024$4.75$4.77+0.42%$4.95$4.76178,159 shs$128.91 million04/26/2024$4.70$4.75+1.06%$4.85$4.65194,533 shs$128.35 million Get the Latest News and Ratings for VTGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$4.72$4.70-0.42%$4.77$4.55193,744 shs$126.99 million04/24/2024$4.83$4.72-2.28%$4.86$4.65147,550 shs$127.53 million04/23/2024$4.78$4.83+1.05%$5.00$4.80189,906 shs$130.51 million04/22/2024$4.76$4.78+0.42%$4.87$4.74138,355 shs$129.16 million04/19/2024$4.70$4.76+1.28%$4.78$4.66152,263 shs$128.62 million04/18/2024$4.67$4.70+0.64%$4.82$4.60194,426 shs$126.99 million04/17/2024$4.65$4.67+0.43%$4.80$4.66116,029 shs$126.18 million04/16/2024$4.75$4.65-2.11%$4.81$4.40180,737 shs$125.64 million04/15/2024$4.89$4.75-2.86%$4.97$4.62274,418 shs$128.37 million04/12/2024$5.31$4.89-7.82%$5.36$4.84321,688 shs$132.13 million04/11/2024$5.10$5.31+4.02%$5.41$5.07227,176 shs$143.37 million04/10/2024$5.37$5.10-5.03%$5.23$5.05168,464 shs$137.83 million04/09/2024$5.17$5.37+3.87%$5.39$5.18173,269 shs$145.10 million04/08/2024$5.04$5.17+2.58%$5.24$5.00115,549 shs$139.69 million04/05/2024$5.29$5.04-4.73%$5.25$4.97259,746 shs$136.18 million04/04/2024$5.38$5.29-1.67%$5.74$5.26447,720 shs$142.94 million04/03/2024$5.40$5.38-0.37%$5.53$5.27187,241 shs$145.37 million04/02/2024$5.40$5.40$5.49$5.07304,312 shs$145.91 million04/01/2024$5.28$5.40+2.27%$5.74$5.08939,925 shs$145.91 million03/29/2024$5.28$5.28$5.67$4.591.24 million shs$142.67 million03/28/2024$4.57$5.28+15.54%$5.67$4.591.23 million shs$142.67 million03/27/2024$4.35$4.57+5.06%$4.65$4.31245,899 shs$123.48 million03/26/2024$4.28$4.35+1.64%$4.42$4.20173,611 shs$117.54 million03/25/2024$4.17$4.28+2.64%$4.42$4.15224,681 shs$115.65 million03/22/2024$4.22$4.17-1.07%$4.24$4.12132,515 shs$112.67 million03/21/2024$4.17$4.22+1.08%$4.29$4.16150,486 shs$113.89 million03/20/2024$4.15$4.17+0.48%$4.41$3.98339,784 shs$112.67 million03/19/2024$4.06$4.15+2.22%$4.25$4.02203,154 shs$112.13 million03/18/2024$4.05$4.06+0.25%$4.29$4.05247,447 shs$109.70 million03/15/2024$3.92$4.05+3.32%$4.11$3.95171,099 shs$109.43 million03/14/2024$4.20$3.92-6.67%$4.20$3.91223,183 shs$105.92 million03/13/2024$4.09$4.20+2.69%$4.37$4.10180,443 shs$113.48 million03/12/2024$4.17$4.09-1.92%$4.19$4.08176,296 shs$110.51 million03/11/2024$4.21$4.17-0.95%$4.31$4.14151,098 shs$112.67 millionAutomatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free.03/08/2024$4.24$4.21-0.59%$4.47$4.19246,907 shs$113.75 million03/07/2024$4.43$4.24-4.40%$4.45$4.21403,439 shs$114.43 million03/06/2024$4.49$4.43-1.34%$4.61$4.40278,434 shs$119.70 million03/05/2024$4.85$4.49-7.42%$4.90$4.45443,588 shs$121.32 million03/04/2024$5.07$4.85-4.34%$5.11$4.85319,310 shs$131.05 million03/01/2024$5.11$5.07-0.78%$5.31$5.02257,492 shs$136.99 million02/29/2024$5.21$5.11-1.92%$5.30$5.11157,312 shs$138.07 million02/28/2024$5.29$5.21-1.51%$5.34$5.12263,787 shs$140.77 million02/27/2024$5.05$5.29+4.86%$5.33$5.00249,178 shs$142.94 million02/26/2024$4.94$5.05+2.13%$5.10$4.94272,302 shs$136.34 million02/23/2024$4.92$4.94+0.41%$5.09$4.87118,420 shs$133.48 million02/22/2024$4.82$4.92+2.18%$5.00$4.80132,705 shs$132.96 million02/21/2024$5.00$4.82-3.70%$5.03$4.76184,139 shs$130.10 million02/20/2024$5.10$5.00-1.96%$5.14$4.95211,377 shs$135.10 million02/19/2024$5.10$5.10$5.39$5.10196,000 shs$137.80 million02/16/2024$5.42$5.10-5.90%$5.39$5.10195,770 shs$137.80 million02/15/2024$5.39$5.42+0.56%$5.55$5.18342,716 shs$146.45 million02/14/2024$4.90$5.39+10.00%$5.46$5.09706,039 shs$145.64 million02/13/2024$5.15$4.90-4.85%$5.01$4.84183,682 shs$132.40 million02/12/2024$4.90$5.15+5.10%$5.40$4.86403,817 shs$139.15 million02/09/2024$4.95$4.90-1.01%$5.00$4.81150,522 shs$132.40 million02/08/2024$4.73$4.95+4.65%$4.99$4.73142,675 shs$133.75 million02/07/2024$4.80$4.73-1.46%$4.86$4.62154,413 shs$127.81 million02/06/2024$4.59$4.80+4.58%$4.85$4.44143,553 shs$129.70 million02/05/2024$4.77$4.59-3.77%$4.72$4.55188,705 shs$124.02 million Related Companies: COYA Stock Price Chart INCR Stock Price Chart SGMT Stock Price Chart AMLX Stock Price Chart PDSB Stock Price Chart ACET Stock Price Chart KPTI Stock Price Chart RNAC Stock Price Chart CTXR Stock Price Chart IMAB Stock Price Chart Receive VTGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VTGN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vistagen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.